Patient Inclusion Criteria:

• Age ≥ 65
• Able to provide informed consent. All patients will be assessed using the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) 56 - a score >14.5 will define ability to independently provide informed consent.
• Eligible patients have Stage III or IV cancer of any type
• Additionally, at least 20 patients will have a will have a high likelihood of MCI based on screening score of <26 on the Montreal Cognitive Assessment (MoCA) within their eRecord chart.
• Able to read and understand English

Patient Exclusion Criteria:

• Patients who do not have decision-making capacity (as determined by UBACC as described above) AND do NOT have a previously designated health care proxy (established prior to their cognitive impairment) available to sign consent.
• Unable to identify caregiver to participate in study.

Caregiver Inclusion Criteria:

• One caregiver for each patient will be eligible and must be chosen by the patient. For the purposes of this study, a caregiver is defined as a valued and trusted person in a patient's life who is supportive in health care matters by providing valuable social support and/or direct assistive care.
• Caregivers will be selected by the patient when asked if there is a "family member, partner, friend or caregiver with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") will remain eligible for the study.
• Age 50 or older
• Ability to provide consent
• Proficient in English

Caregiver Exclusion Criteria

• Caregivers unable to understand the consent form due to cognitive, health or sensory impairment will be excluded